Ipilimumab administration for advanced melanoma in patients with pre-existing Hepatitis B or C infection: a multicenter, retrospective case series

Ipilimumab is a fully human, monoclonal antibody directed against Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) that has demonstrated a survival benefit and durable disease control in patients with advanced melanoma. Ipilimumab is associated with potentially serious immune-related adverse events, includ...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ravi, Sowmya, Spencer, Kristen, Ruisi, Mary, Ibrahim, Nageatte, Luke, Jason J, Thompson, John A, Shirai, Keisuke, Lawson, David, Bartell, Heddy, Kudchadkar, Ragini, Gunter, Ngoc Thi, Mehnert, Janice M, Lipson, Evan J
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4195895/
https://ncbi.nlm.nih.gov/pubmed/25317333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-014-0033-1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires